Trial Profile
Multicentre Open Study on the Efficacy and Safety of Botulinum Toxin A (500 Units Dysport®) in the Treatment of Heterogeneous Forms of Cervical Dystonia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Apr 2023
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Registrational; Therapeutic Use
- Sponsors Ipsen
- 24 Jun 2014 New trial record
- 23 Jul 2009
- 01 Apr 2008